1.
Kemanetzi C, Lallas K, Lazaridou E, Papageorgiou C, Lallas A, Stratigos A, et al. The Impact of Immune Checkpoint Inhibitors-Induced Skin Toxicity on Patients’ Quality of Life and the Role of Dermatologic Intervention. Dermatol Pract Concept [Internet]. 2024 Jul. 31 [cited 2025 Jan. 24];14(3):e2024118. Available from: https://www.dpcj.org/index.php/dpc/article/view/3884